Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor

被引:20
|
作者
Emani, Sirisha [1 ]
Ramlawi, Basel [1 ]
Sodha, Neel R. [1 ]
Li, Jian [1 ]
Bianchi, Cesario [1 ]
Sellke, Frank W. [1 ]
机构
[1] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA
来源
关键词
FACTOR-I; VEGF; ACTIVATION; HYPOXIA; PROLIFERATION; ANGIOGENESIS; KINASE; CELLS;
D O I
10.1016/j.jtcvs.2008.12.024
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several inflammatory mediators such as vascular endothelial growth factor and hepatocyte growth factor are known to play a critical role in the regulation of vascular permeability and angiogenesis. We studied the serum levels of growth factors and gene expression profiles of genes involved in growth factor signaling in the peripheral blood of patients with and patients without diabetes following cardiopulmonary bypass and cardioplegic arrest. Methods: Serum and total RNA were obtained from the blood samples collected from patients with diabetes and matched patients without diabetes (n = 7 patients each) who had coronary artery bypass graft before and 6 hours and 4 days after cardiopulmonary bypass/cardioplegic arrest. The cytokine panel, consisting of growth factors such as vascular endothelial growth factor, hepatocyte growth factor, fibroblast growth factor, and epidermal growth factor, was quantified in patients with diabetes and patients without diabetes before and 6 hours and 4 days post-cardiopulmonary bypass/cardioplegic arrest using multiplex cytokine quantification system. cDNA microarray analysis was performed and fold-change was calculated. Results: Length of hospitalization (10 vs 6 days; P = .04) and weight gain (5 vs 2.5 kg; P = .001) were significantly greater for patients with diabetes compared with patients without diabetes. The serum levels of vascular endothelial growth factor and hepatocyte growth factor were significantly elevated in patients with diabetes when compared with patients without diabetes before versus 6 hours post-cardiopulmonary bypass/cardioplegic arrest. In addition, significantly elevated mRNA expression of hypoxia-inducible factor-1 alpha, cyclic adenosine monophosphate response element binding protein, and E1A binding protein p300 (more than twofold) was observed 4 days post-cardiopulmonary bypass/cardioplegic arrest exclusively in patients with diabetes. Conclusions: The differential profile of gene and protein expression of growth factors and their related genes in patients with diabetes and patients without diabetes could be associated with increased edema and weight gain in patients with diabetes after cardiopulmonary bypass/cardioplegic arrest.
引用
收藏
页码:185 / 191
页数:7
相关论文
共 50 条
  • [41] Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
    Guidi, AJ
    Schnitt, SJ
    Fischer, L
    Tognazzi, K
    Harris, JR
    Dvorak, HF
    Brown, LF
    CANCER, 1997, 80 (10) : 1945 - 1953
  • [42] Vascular endothelial growth factor (VEGF) expression in the subacromial bursa is increased in patients with impingement syndrome
    Yanagisawa, K
    Hamada, K
    Gotoh, M
    Tokunaga, T
    Oshika, Y
    Tomisawa, M
    Lee, YH
    Handa, A
    Kijima, H
    Yamazaki, H
    Nakamura, M
    Ueyama, Y
    Tamaoki, N
    Fukuda, H
    JOURNAL OF ORTHOPAEDIC RESEARCH, 2001, 19 (03) : 448 - 455
  • [43] Increased expression of vascular endothelial growth factor in skin biopsies of patients with amyotrophic lateral sclerosis
    Ono, S
    Yamazaki, T
    Irie, T
    Shiraishi, H
    Wakayama, K
    Suzuki, M
    Shimizu, N
    ANNALS OF NEUROLOGY, 2004, 56 : S21 - S22
  • [45] Increased vascular endothelial growth factor in acute eosinophilic pneumonia
    Nishigaki, Y
    Fujiuchi, S
    Yamazaki, Y
    Matsumoto, H
    Takeda, A
    Fujita, Y
    Okamoto, K
    Fujikane, T
    Shimizu, T
    Kikuchi, K
    EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (05) : 774 - 778
  • [46] Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
    Guidi, AJ
    AbuJawdeh, G
    Tognazzi, K
    Dvorak, HF
    Brown, LF
    CANCER, 1996, 78 (03) : 454 - 460
  • [47] Significant expression of vascular endothelial growth factor vascular permeability factor in mouse ascites tumors
    Luo, JC
    Yamaguchi, S
    Shinkai, A
    Shitara, K
    Shibuya, M
    CANCER RESEARCH, 1998, 58 (12) : 2652 - 2660
  • [48] Increased circulating levels of vascular endothelial growth factor in preeclampsia
    Brockelsby, JC
    Wheeler, T
    Anthony, FW
    Wellings, R
    Baker, PN
    HYPERTENSION IN PREGNANCY, 1998, 17 (03) : 283 - 290
  • [49] Increased vascular endothelial growth factor (VEGF) immunostaining in preeclampsia
    Simmons, LA
    Hennessy, A
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 49A - 49A
  • [50] Prostaglandin use is associated with increased vascular endothelial growth factor in the aqueous humor of glaucoma patients
    Kwon, Jin-woo
    Jee, Donghyun
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2017, 45 (05): : 549 - 551